The researchers — led by Sarah J. Iribarren, PhD, of University of Washington School of Nursing in Seattle — identified 39 studies that evaluated the economic outcomes of mobile health interventions. These studies focused on primary healthcare and behavioral changes, such as outpatient clinic attendance and managing cardiovascular disease or diabetes.
In 74.3 percent of studies, researchers noted that the mobile health intervention was “cost-effective, economically beneficial or cost saving at base case.”
The researchers concluded that their systematic review identified a “growing body of economic evidence for mHealth interventions.” However, they acknowledge that “the identified economic evaluations varied by disease or condition focus, economic outcome measurements, perspectives and were distributed unevenly geographically, limiting formal meta-analysis.”
More articles on health IT:
Study: Do patients want to receive emails from their provider?
International research team partners with IBM to identify childhood cancer treatments
10% of spam emails are ‘malicious’: 4 things to know
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.